查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423953

狗疫苗市場、份額、規模、趨勢、行業分析報告：按疫苗類型、按疾病類型、按給藥途徑、按免疫持續時間、按成分、按地區、按細分市場預測，2024-2032 年

Dog Vaccine Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2032年，全球狗疫苗市場規模將達到27.0828億美元。 該報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於寵物健康和更廣泛的獸藥行業日益重要的綜合因素，犬疫苗市場近年來經歷了顯著增長。 這一市場擴張背後的驅動力之一是狗主人越來越意識到接種疫苗預防狗的各種疾病的好處。 隨著越來越多的人意識到與犬類疾病相關的潛在風險，對有效疫苗的需求不斷增長，以保護他們心愛的寵物免受這些健康威脅。

此外，獸醫研究和技術的進步正在促進功效和安全性更高的創新疫苗的開發。 這不僅擴大了可預防疾病的範圍，也提高了犬類醫療照護的整體品質。 獸醫專業人員比以往任何時候都更有能力提供量身定制的疫苗接種方案，以滿足每隻狗的獨特需求，同時考慮到年齡、品種和生活方式等因素。我們已做好準備。

此外，監管措施和公共衛生運動在塑造狗疫苗市場的動態方面發揮關鍵作用。 世界各地的政府機構和獸醫協會積極倡導負責任的寵物飼養，並強調定期接種疫苗作為預防性醫療保健基石的重要性。 這些共同努力為獸用疫苗領域的研發創造了更有利的監管環境並增加了公共資金。

此外，寵物人性化的趨勢進一步推動了對先進醫療解決方案（包括疫苗）的需求，以確保狗的福祉和長壽。 寵物主人越來越多地將他們的狗視為家庭的重要成員，因此願意投資預防措施來幫助他們的狗過上更健康的生活。 這種將寵物視為家庭成員的文化轉變為疫苗製造商創造了利潤豐厚的市場機會，並培育了以不斷創新和產品開發為特徵的競爭格局。

狗疫苗市場報告亮點

減毒疫苗在市場上佔據主導地位，因為它有助於預防疾病並提供長期免疫力

狂犬病預計將快速增長，主要是因為其高盛行率和人畜共患病的可能性。

由於寵物數量眾多以及寵物主人意識的不斷增強，亞太地區將以最快的速度增長。

目錄

第一章簡介

  • 報告說明
    • 研究目的
    • 市場範圍
    • 假設
  • 利害關係人

第 2 章執行摘要

第3章研究方法

第4章全球狗疫苗市場洞察

  • 犬疫苗市場－免疫期概況
  • 犬隻疫苗市場動態
    • 推動者和機會
      • 養寵物的現像日益普遍
      • 獸醫學的進展
    • 抑制因素和挑戰
      • 疫苗成本高
  • PESTEL 分析
  • 犬疫苗市場免疫期趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第5章全球狗疫苗市場（依疾病類型）

  • 主要發現
  • 簡介
  • 犬瘟熱
  • 犬傳染性呼吸道疾病綜合體 (CIRDC)
  • 犬小病毒病/小病毒病
  • 犬鉤端螺旋體病
  • 狗的萊姆病
  • 犬傳染性肝炎
  • 狂犬病
  • 其他

第 6 章全球狗疫苗市場（依疫苗類型）

  • 主要發現
  • 簡介
  • 退化/壽命減弱
  • 失活（失活）
  • 其他

第7章全球狗疫苗市場，依免疫期劃分

  • 主要發現
  • 簡介
  • 1 年
  • 3年
  • 其他

第 8 章全球狗疫苗市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年犬隻疫苗市場評估（按地區）
  • 狗疫苗市場 - 北美
    • 北美：狗疫苗市場，依疾病類型，2019-2032 年
    • 北美：狗疫苗市場，依免疫期劃分，2019-2032 年
    • 北美：狗疫苗市場，依疫苗類型，2019-2032 年
    • 狗狗疫苗市場 - 美國
    • 狗疫苗市場 - 加拿大
  • 犬疫苗市場 - 歐洲
    • 歐洲：2019-2032 年按疾病類型劃分的狗疫苗市場
    • 歐洲：狗疫苗市場，依免疫期劃分，2019-2032 年
    • 歐洲：2019-2032 年狗狗疫苗市場（以疫苗類型）
    • 狗狗疫苗市場 - 英國
    • 犬疫苗市場 - 法國
    • 狗狗疫苗市場 - 德國
    • 狗疫苗市場 - 義大利
    • 狗狗疫苗市場 - 西班牙
    • 犬疫苗市場 - 荷蘭
    • 狗狗疫苗市場 - 俄羅斯
  • 犬疫苗市場 - 亞太地區
    • 亞太地區：狗疫苗市場，依疾病類型，2019-2032 年
    • 亞太地區：狗疫苗市場，依免疫期劃分，2019-2032 年
    • 亞太地區：狗疫苗市場，依疫苗類型，2019-2032 年
    • 狗狗疫苗市場 - 中國
    • 犬疫苗市場 - 印度
    • 犬疫苗市場 - 馬來西亞
    • 狗狗疫苗市場 - 日本
    • 犬疫苗市場 - 印度尼西亞
    • 犬疫苗市場－韓國
  • 狗狗疫苗市場 - 中東和非洲
    • 中東和非洲：2019-2032 年狗疫苗市場（按疾病類型）
    • 中東和非洲：狗疫苗市場，按免疫期劃分，2019-2032 年
    • 中東和非洲：2019-2032 年狗疫苗市場（按疫苗類型）
    • 犬疫苗市場－沙烏地阿拉伯
    • 犬疫苗市場 - 阿拉伯聯合大公國
    • 狗狗疫苗市場 - 以色列
    • 狗疫苗市場 - 南非
  • 犬疫苗市場 - 拉丁美洲
    • 拉丁美洲：狗疫苗市場，依疾病類型劃分，2019-2032 年
    • 拉丁美洲：狗疫苗市場，按免疫期劃分的狗疫苗市場，2019-2032 年
    • 拉丁美洲：2019-2032 年狗疫苗市場（以疫苗類型）
    • 狗狗疫苗市場 - 墨西哥
    • 狗狗疫苗市場 - 巴西
    • 犬疫苗市場 - 阿根廷

第9章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章公司簡介

  • Bioveta a.s
  • .Hester Biosciences Limited
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma
  • Heska Corporation
  • Merck & Co., Inc.
  • Virbac
  • Zendal Group
  • Elanco
  • Zoetis Services
Product Code: PM4185

The global dog vaccine market size is expected to reach USD 2,708.28 million by 2032, according to a new study by Polaris Market Research. The report "Dog Vaccine Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The dog vaccine market has experienced significant growth in recent years, driven by a combination of factors that underscore the increasing importance of pet health and the broader veterinary pharmaceutical industry. One of the primary driving forces behind this expansion is the rising awareness among pet owners about the benefits of vaccination in preventing various diseases in dogs. As more individuals become informed about the potential risks associated with canine illnesses, there is a heightened demand for effective vaccines that can safeguard their beloved pets from these health threats.

Furthermore, advancements in veterinary research and technology have facilitated the development of innovative vaccines with improved efficacy and safety profiles. This has not only expanded the range of diseases that can be prevented but also enhanced the overall quality of canine healthcare. Veterinary professionals are now better equipped than ever to provide tailored vaccination protocols that address the unique needs of individual dogs, considering factors such as age, breed, and lifestyle.

Additionally, regulatory initiatives and public health campaigns have played a pivotal role in shaping the dynamics of the dog vaccine market. Governmental organizations and veterinary associations across the globe have been actively promoting responsible pet ownership and emphasizing the importance of regular vaccinations as a cornerstone of preventive healthcare. These concerted efforts have contributed to a more favorable regulatory environment and increased public funding for research and development in the veterinary vaccine sector.

Moreover, the growing trend of humanization of pets has further propelled the demand for advanced healthcare solutions, including vaccines, to ensure the well-being and longevity of dogs. Pet owners are increasingly viewing their canine companions as integral members of their families and are therefore willing to invest in preventive measures that can help them lead healthier lives. This cultural shift towards treating pets as family members has created a lucrative market opportunity for vaccine manufacturers and has fostered a competitive landscape characterized by continuous innovation and product development.

Dog Vaccine Market Report Highlights

Attenuated vaccine segment dominated the market, as it helps in preventing disease and provides long term immunity

Canine rabies segment will grow at the rapid pace, primarily due to its high prevalence rate, and its zoonotic potential

APAC to grow at the fastest rate, owing to the presence of large number of pets in the region and growing awareness among pet owners

The global players include Bioveta, Hester Biosciences, Boehringer Ingelheim, Brilliant Bio Pharma, Heska Corp., Merck, Virbac, Elanco, and Zoetis Services

Polaris Market Research has segmented the dog vaccine market report based on vaccine type, disease type, duration of immunity, and region:

Dog Vaccine, Vaccine Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Modified/ Attenuated Live
  • Inactivated (Killed)
  • Others

Dog Vaccine, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Canine Distemper
  • Canine Infectious Respiratory Disease Complex (CIRDC)
  • Canine Parvovirosis/ Parvovirus Disease
  • Canine Leptospirosis
  • Canine Lyme Disease
  • Infectious Canine Hepatitis
  • Canine Rabies
  • Others

Dog Vaccine, Duration of Immunity Outlook (Revenue - USD Million, 2019 - 2032)

  • 1-Year
  • 3-Year
  • Others

Dog Vaccine, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dog Vaccine Market Insights

  • 4.1. Dog Vaccine Market - Duration of Immunity Snapshot
  • 4.2. Dog Vaccine Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Pet Adoption Rates
      • 4.2.1.2. Advancements in Veterinary Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Vaccines
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Dog Vaccine Market Duration of Immunity Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Dog Vaccine Market, by Disease Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • 5.3. Canine Distemper
    • 5.3.1. Global Dog Vaccine Market, by Canine Distemper, by Region, 2019-2032 (USD Million)
  • 5.4. Canine Infectious Respiratory Disease Complex (CIRDC)
    • 5.4.1. Global Dog Vaccine Market, by Canine Infectious Respiratory Disease Complex (CIRDC), by Region, 2019-2032 (USD Million)
  • 5.5. Canine Parvovirosis/ Parvovirus Disease
    • 5.5.1. Global Dog Vaccine Market, by Canine Parvovirosis/ Parvovirus Disease, by Region, 2019-2032 (USD Million)
  • 5.6. Canine Leptospirosis
    • 5.6.1. Global Dog Vaccine Market, by Canine Leptospirosis, by Region, 2019-2032 (USD Million)
  • 5.7. Canine Lyme Disease
    • 5.7.1. Global Dog Vaccine Market, by Canine Lyme Disease, by Region, 2019-2032 (USD Million)
  • 5.8. Infectious Canine Hepatitis
    • 5.8.1. Global Dog Vaccine Market, by Infectious Canine Hepatitis, by Region, 2019-2032 (USD Million)
  • 5.9. Canine Rabies
    • 5.9.1. Global Dog Vaccine Market, by Canine Rabies, by Region, 2019-2032 (USD Million)
  • 5.10. Others
    • 5.10.1. Global Dog Vaccine Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Dog Vaccine Market, by Vaccine Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 6.3. Modified/ Attenuated Live
    • 6.3.1. Global Dog Vaccine Market, by Modified/ Attenuated Live, by Region, 2019-2032 (USD Million)
  • 6.4. Inactivated (Killed)
    • 6.4.1. Global Dog Vaccine Market, by Inactivated (Killed), by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Dog Vaccine Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Dog Vaccine Market, by Duration of Immunity

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • 7.3. 1-Year
    • 7.3.1. Global Dog Vaccine Market, by 1-Year, By Region, 2019-2032 (USD Million)
  • 7.4. 3-Year
    • 7.4.1. Global Dog Vaccine Market, by 3-Year, By Region, 2019-2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Dog Vaccine Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Dog Vaccine Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Dog Vaccine Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Dog Vaccine Market - North America
    • 8.3.1. North America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.3.3. North America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.3.4. Dog Vaccine Market - U.S.
      • 8.3.4.1. U.S.: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.3.5. Dog Vaccine Market - Canada
      • 8.3.5.1. Canada: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.4. Dog Vaccine Market - Europe
    • 8.4.1. Europe: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.4.3. Europe: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.4. Dog Vaccine Market - UK
      • 8.4.4.1. UK: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.5. Dog Vaccine Market - France
      • 8.4.5.1. France: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.5.3. France: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.6. Dog Vaccine Market - Germany
      • 8.4.6.1. Germany: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.7. Dog Vaccine Market - Italy
      • 8.4.7.1. Italy: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.8. Dog Vaccine Market - Spain
      • 8.4.8.1. Spain: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.9. Dog Vaccine Market - Netherlands
      • 8.4.9.1. Netherlands: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.4.10. Dog Vaccine Market - Russia
      • 8.4.10.1. Russia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.5. Dog Vaccine Market - Asia Pacific
    • 8.5.1. Asia Pacific: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.4. Dog Vaccine Market - China
      • 8.5.4.1. China: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.4.3. China: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.5. Dog Vaccine Market - India
      • 8.5.5.1. India: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.5.3. India: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.6. Dog Vaccine Market - Malaysia
      • 8.5.6.1. Malaysia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.7. Dog Vaccine Market - Japan
      • 8.5.7.1. Japan: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.8. Dog Vaccine Market - Indonesia
      • 8.5.8.1. Indonesia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.5.9. Dog Vaccine Market - South Korea
      • 8.5.9.1. South Korea: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.6. Dog Vaccine Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.4. Dog Vaccine Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.5. Dog Vaccine Market - UAE
      • 8.6.5.1. UAE: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.6. Dog Vaccine Market - Israel
      • 8.6.6.1. Israel: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.6.7. Dog Vaccine Market - South Africa
      • 8.6.7.1. South Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • 8.7. Dog Vaccine Market - Latin America
    • 8.7.1. Latin America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.7.4. Dog Vaccine Market - Mexico
      • 8.7.4.1. Mexico: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.7.5. Dog Vaccine Market - Brazil
      • 8.7.5.1. Brazil: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
    • 8.7.6. Dog Vaccine Market - Argentina
      • 8.7.6.1. Argentina: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bioveta a.s
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Hester Biosciences Limited
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boehringer Ingelheim International GmbH
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Brilliant Bio Pharma
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Heska Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck & Co., Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Virbac
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Zendal Group
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Elanco
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Zoetis Services
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 2 Global Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 3 Global Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 4 Dog Vaccine Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 6 North America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 7 North America: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 8 U.S.: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 11 Canada: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 12 Canada: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 13 Canada: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 14 Europe: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 15 Europe: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 16 Europe: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 17 UK: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 18 UK: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 19 UK: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 20 France: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 21 France: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 22 France: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 23 Germany: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 24 Germany: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 25 Germany: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 26 Italy: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 27 Italy: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 28 Italy: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 29 Spain: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 30 Spain: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 31 Spain: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 32 Netherlands: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 34 Netherlands: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 35 Russia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 36 Russia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 37 Russia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 41 China: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 42 China: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 43 China: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 44 India: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 45 India: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 46 India: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 47 Malaysia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 49 Malaysia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 50 Japan: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 51 Japan: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 52 Japan: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 53 Indonesia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 55 Indonesia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 56 South Korea: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 58 South Korea: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 65 UAE: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 66 UAE: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 67 UAE: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 68 Israel: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 69 Israel: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 70 Israel: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 71 South Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 73 South Africa: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 74 Latin America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 76 Latin America: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 77 Mexico: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 79 Mexico: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 80 Brazil: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 82 Brazil: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
  • Table 83 Argentina: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
  • Table 85 Argentina: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Dog Vaccine Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Vaccine Type
  • Figure 7. Global Dog Vaccine Market, by Vaccine Type, 2022 & 2032 (USD Million)
  • Figure 8. Market by Disease Type
  • Figure 9. Global Dog Vaccine Market, by Disease Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by Duration of Immunity
  • Figure 11. Global Dog Vaccine Market, by Duration of Immunity, 2022 & 2032 (USD Million)
  • Figure 12. Dog Vaccine Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Dog Vaccine Market